Trial intelligence / Profile preview

Intracoronary Nicorandil in STEMI

NCT02435797Phase 4Unknown

Sponsor
Xuzhou Central Hospital
Start
Apr 2015
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nicorandil in ST elevation myocardial infarction (STEMI), sponsored by Xuzhou Central Hospital. Status: unknown.

02

Drugs

nicorandil
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02435797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02435797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call